Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?"

Dig Liver Dis. 2016 Sep;48(9):1101-2. doi: 10.1016/j.dld.2016.06.017. Epub 2016 Jun 28.

Authors

Ester Vanni¹, Elisabetta Bugianesi², Giorgio Maria Saracco³

Affiliations

¹ Gastroenterology Unit, Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: ester.vanni@unito.it.
² Gastroenterology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
³ Gastroenterology Unit, Department of Oncology, University of Turin, Turin, Italy.

PMID: 27443491
DOI: 10.1016/j.dld.2016.06.017

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents
Diabetes Mellitus
Hepatitis C, Chronic*
Humans
Ribavirin*

Substances

Antiviral Agents
Ribavirin